Survival benefit of radiofrequency ablation for solitary (3–5 cm) hepatocellular carcinoma: An analysis for nationwide cancer registry

We retrospectively compared overall survival (OS) and progression-free survival (PFS) of patients with single (3–5 cm) hepatocellular carcinoma (HCC) with Barcelona Clinic Liver Cancer (BCLC) stage A treated by surgical resection (SR), radiofrequency ablation (RFA), or transarterial chemoembolizatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Seung Ho, Jin, Young-Joo, Lee, Jin-Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682826/
https://www.ncbi.nlm.nih.gov/pubmed/29095307
http://dx.doi.org/10.1097/MD.0000000000008486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682826/
https://www.ncbi.nlm.nih.gov/pubmed/29095307
http://dx.doi.org/10.1097/MD.0000000000008486

Ejemplares similares